Quoted Portfolio Companies
Unquoted Portfolio Companies
Sold Companies
 
Monday, May 12, 2008

CeNeS logo 
 
CeNeS is a biopharmaceutical company specialising in the development and commercialisation of drugs from pain control, sedation and other CNS disorders such as Parkinson’s disease.

24 November 2003
TheraSci Limited was acquired by CeNeS
 
view website 
 
 

Privacy Statement | Sitemap | © 2008 Avlar BioVentures Limited

Avlar BioVentures Limited is authorised and regulated by the Financial Services Authority, who require us to state that investments of this type are only suitable for experienced investors familiar with venture capital and biotechnology companies.